Clinical utility of avidity assays

Expert Opinion on Medical Diagnostics

Volumn 1, Issue 4, 2007, Pages 511-519

  Hazell, Stuart L ^a  

^a PANBIO Ltd   (Australia)

Author keywords

affinity maturation; avidity testing; cytomegalovirus; IgG; IgG avidity; IgM; Toxoplasma gondii; West Nile virus

Indexed keywords

EID: 80052134746     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.1.4.511     Document Type: Article

References (61)

1. ROEHRIG JT, NASH D, MALDIN B et al. : Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg. Infect. Dis. (2003) 9 : 376-379. (Pubitemid 36330881)
2. GIRALDO M, PORTELA RWD, SNEGE M et al. : Immunoglobulin M (IgM)-glycoinositolphospholipid enzyme-linked immunosorbent assay: an immunoenzymatic assay for discrimination between patients with acute Toxoplasmosis and those with persistent parasite-specific IgM antibodies. J. Clin. Microbiol. (2002) 40 : 1400-1405. (Pubitemid 34279908)
3. PINON JM, DUMON H, CHEMLA C et al. : Strategy for diagnosis of congenital Toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of Immunoglobulin G, M, and A antibodies. J. Clin. Microbiol. (2001) 39 : 2267-2271. (Pubitemid 32531492)
4. OKUMURA K, METZLER CM, TSU TT, HERZENBERG LA, HERZENBERG LA: Two stages of B-cell memory development with different T-cell requirements. J. Exp. Med. (1976) 144 : 345-357.
5. STEININGER C, KUNDI M, KLETZMAYR J, ABERLE SW, POPOW-KRAUPP T: Antibody maturation and viremia after primary Cytomegalovirus infection in immunocompetent patients and kidney-transplant patients. J. Infect. Dis. (2004) 190 : 1908-1912. (Pubitemid 39564694)
6. EISEN HN, SISKIND GW: Variations in affinities of antibodies during the immune response. Biochemistry (1964) 3 : 996-1008.
7. LEHTONEN OP, MEURMAN OH: An ELISA for the estimation of high-avidity and total specific IgG and IgM antibodies to rubella virus. J. Virol. Methods (1982) 5 : 1-10. (Pubitemid 12029773)
8. INOUYE S, HASEGAWA A, MATSUNO S, KATOW S: Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J. Clin. Microbiol. (1984) 20 : 525-529. (Pubitemid 14073422)
9. STEWARD MW, LEW AM: The importance of antibody affinity in the performance of immunoassays for antibody. J. Immunol. Methods (1985) 78 : 173-190. (Pubitemid 15109176)
10. HEDMAN K, SEPPÄ LÄ I: Recent rubella virus infection indicated by a low avidity of specific IgG. J. Clin. Immunol. (1988) 8 : 214-221.
11. KORHÔNEN MH, BRUNSTEIN J, HAARIO H et al. : A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin. Diag. Lab. Immunol. (1999) 6 : 725-728.
12. FOX JL, HAZELL SL, TOBLER LH, BUSCH MP: Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus. Clin. Vacc. Immunol. (2006) 13 : 33-36.
13. JENUM PA, STRAY-PEDERSEN B, GUNDERSEN A-G: Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma Immunoglobulin G avidity. J. Clin. Microbiol. (1997) 35 : 1972-1977. (Pubitemid 27318688)
14. CHAWLA A, MURPHY G, DONNELLY C et al. : Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV Type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J. Clin. Microbiol. (2007) 45 : 415-420.
15. COOK AJC, GILBERT RE, BUFFOLANO W et al. : Sources of toxoplasma infection in pregnant women: European multicentre case control study. Br. Med. J. (2000) 321 : 142-147. (Pubitemid 30447005)
16. DUNN D, WALLON M, PEYRON F et al. : Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet (1999) 353 : 1829-1833. (Pubitemid 29251014)
17. MONTOYA JG, LIESENFELD O, KINNEY S, PRESS C, REMINGTON JS: VIDAS test for avidity of Toxoplasma-specific Immunoglobulin G for confirmatory testing of pregnant women. J. Clin. Microbiol. (2002) 40 : 2504-2508. (Pubitemid 34747355)
18. BEGHETTO E, BUFFOLANO W, SPADONI A et al. : Use of an Immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J. Clin. Microbiol. (2003) 41 : 5414-5418. (Pubitemid 37543225)
19. MORTENSEN PB, NØRGAARD-PEDERSEN B, WALTOFT BL et al. : Early Infections of Toxoplasma gondii and the later development of Schizophrenia. Schizophr. Bull. (2007) 33 : 741-744. (Pubitemid 47343716)
20. DAFFOS F, FORESTIER F, CAPELLA-PAVLOVSKY M et al. : Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N. Engl. J. Med. (1988) 318 : 271-275. (Pubitemid 18034517)
21. HOHLFELD P, DAFFOS F, THULLIEZ P et al. : Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J. Pediatr. (1989) 115 : 765-769. (Pubitemid 19270273)
22. MCAULEY J, BOYER KM, PATEL D et al. : Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clin. Infect. Dis. (1994) 18 : 38-72. (Pubitemid 24025917)
23. THE SYROCOT (SYSTEMATIC REVIEW ON CONGENITAL TOXOPLASMOSIS) STUDY GROUP: Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patientsï data. Lancet (2007) 369 : 115-122.
24. TAN HK, SCHMIDT D, STANFORD M et al. : The European multicentre study on congenital toxoplasmosis (EMSCOT); risk of visual impairment in children with congenital toxoplasmic retinochoroiditis. Am. J. Ophthalmol. (2007) 144 : 648-653.
25. HOHLFELD P, DAFFOS F, COSTA JM et al. : Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain reaction test on amniotic fluid. N. Engl. J. Med. (1994) 331 : 695-699.
26. FRANCIS JM, JOYNSON D.H.M.: Duration of specific immunoglobulin A antibody following acute toxoplasmosis as determined by enzyme immunoassay and immunosorbent agglutination assay. Eur. J. Clin. Microbiol. Infect. Dis. (1993) 12 : 556-559. (Pubitemid 23241809)
27. WONG SY, REMINGTON JS: Toxoplasmosis in pregnancy. Clin. Infect. Dis. (1994) 18 : 853-862. (Pubitemid 2111086)
28. NAESSENS A, HEUNINCKX W, FOULON W, LAUWERS S: Evaluation of seven commercially available enzyme immunoassays for immunoglobulin G and M antibody detection of Toxoplasma gondii . Immunol. Infect. Dis. (1993) 3 : 258-262.
29. LEBECH M, JOYNSON D.H.M., SEITZ HM et al. : Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur. J. Clin. Microbiol. Infect. Dis. (1996) 15 : 799-805. (Pubitemid 26386122)
30. FRANCIS JM, JOYNSON DH: Duration of specific immunoglobulin A antibody following acute toxoplasmosis as determined by enzyme immunoassay and immunosorbent agglutination assay. Eur. J. Clin. Microbiol. Infect. Dis. (1993) 12 : 556-559. (Pubitemid 23241809)
31. NIMRI L, PELLOUX H, ELKHATIB L: Detection of Toxolplasma gondii DNA and specific antibodies in high risk pregnant women. Am. J. Trop. Med. Hyg. (2004) 71 : 831-835. (Pubitemid 40075638)
32. PETERSEN E, BOROBIO MV, GUY E et al. : European multicenter study of the Liaison automated diagnostic system for determination of Toxoplasma gondii-specific Immunoglobulin G (IgG) and IgM and the IgG avidity index. J. Clin. Microbiol. (2005) 43 : 1570-1574.
33. LIESENFELD O, MONTOYA JG, KINNEY S, PRESS C, REMINGTON JS: Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J. Infect. Dis. (2001) 183 : 1248-1253. (Pubitemid 32281564)
34. MONTOYA JG, LIESENFELD O, KINNEY S, PRESS C, REMINGTON JS: VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J. Clin. Microbiol. (2002) 40 : 2504-2508. (Pubitemid 34747355)
35. PELLOUX H, BRUN E, VERNET G et al. : Determination of anti- Toxoplasma gondii immunoglobulin G avidity: adaptation to the VIDAS system (BioMerieux). Diagn. Microbiol. Infect. Dis. (1998) 32 : 69-73. (Pubitemid 28526445)
36. CANDOLFI E, PASTOR R, HUBER R et al. : IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women. Diag. Microbiol. Infect. Dis. (2007) 58 : 83-88. (Pubitemid 46694277)
37. MARCOLINO PT, SILVA DA, LESER PG et al. : Molecular markers in acute and chronic phases of human toxoplasmosis: determination of immunoglobulin G avidity by western blotting. Clin. Diagn. Lab. Immunol. (2000) 7 : 384-389. (Pubitemid 30263029)
38. VILLAVEDRA M, BATTISTONI J, NIETO A: IgG recognizing 21-24 kDa and 30-33 kDa tachyzoite antigens show maximum avidity maturation during natural and accidental human toxoplasmosis. Rev. Inst. Med. Trop. Sao Paulo (1999) 41 : 297-303.
39. PFREPPER K-I, ENDERS G, GOHL M et al. : Seroreactivity to and avidity for recombinant antigens in Toxoplasmosis. Clin. Diagn. Lab. Immunol. (2005) 12 : 977-982.
40. REVELLO MG, GERNA G: Diagnosis and management of human Cytomegalovirus infection in the mother, fetus, and newborn infant. Clin. Mirco. Rev. (2002) 15 : 680-715. (Pubitemid 41184084)
41. MUNRO SC, HALL B, WHYBIN LR et al. : Diagnosis of and screening for Cytomegalovirus infection in pregnant women. J. Clin. Microbiol. (2005) 43 : 4713-4718. (Pubitemid 41298268)
42. FOWLER KB, STAGNO S, PASS RF et al. : The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med. (1992) 326 : 663-667.
43. KUMAR ML, PROKAY SL: Experimental primary cytomegalovirus infection in pregnancy: timing and fetal outcome. Am. J. Obstet. Gynecol. (1983) 145 : 56-60. (Pubitemid 13225343)
44. STAGNO S, PASS RF, CLOUD G et al. : Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA (1986) 256 : 1904-1908.
45. GUERRA B, LAZZAROTTO T, QUARTA S et al. : Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am. J. Obstet. Gynecol. (2000) 183 : 476-482. (Pubitemid 30651101)
46. LAZZAROTTO T, SPEZZACATENA P, VARANI S et al. : Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection. Clin. Diagn. Lab. Immunol. (1999) 6 : 127-129. (Pubitemid 29035651)
47. BODEUS M, HUBINONT C, BERNARD P et al. : Prenatal diagnosis of human cytomegalovirus by culture and polymerase chain reaction: 98 pregnancies leading to congenital infection. Prenatal. Diagn. (1999) 19 : 314-317. (Pubitemid 29184820)
48. LIPITZ S, YAGEL S, SHALEV E et al. : Prenatal diagnosis of fetal primary cytomegalovirus infection. Obstet. Gynecol. (1997) 89 : 763-767. (Pubitemid 27184862)
49. DONNER C, LIESNARD C, BRANCART F, RODESCH F: Accuracy of amniotic fluid testing before 21 weeks gestation in prenatal diagnosis of congenital cytomegalovirus infection. Prenatal. Diagn. (1994) 14 : 1055-1059. (Pubitemid 24362067)
50. LIESNARD C, DONNER C, BRANCART F et al. : Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet. Gynecol. (2000) 95 : 881-888.
51. BACCARD-LONGERE M, FREYMUTH F, COINTE D et al. : Multicenter evaluation of a rapid and convenient method for determination of Cytomegalovirus immunoglobulin G avidity. Clin. Diagn. Lab. Immunol. (2001) 8 : 429-431. (Pubitemid 32217078)
52. BODÉUS M, VAN RANST M, BERNARD P et al. : Anticytomegalovirus IgG avidity in pregnancy: a 2-year prospective study. Fetal Diagnosis Ther. (2002) 17 : 362-366. (Pubitemid 36160159)
53. LANCIOTTI RS, ROEHRIG JT, DEUBEL V et al. : Origin of the West Nile virus responsible for an outbreak of Encephalitis in the Northeastern United States. Science (1999) 286 : 2333-2337. (Pubitemid 30016893)
54. LEVETT PN, SONNENBERG K, SIDAWAY F et al. : Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus J. Clin. Microbiol. (2005) 43 : 5873-5875. (Pubitemid 43100631)
55. PRINCE HE, LAPÉ-NIXON M, BUSCH MP et al. : Utilization of follow-up specimens from viremic blood donors to assess the value of West Nile virus immunoglobulin G avidity as an indicator of recent infection Clin. Diagn. Lab. Immunol. (2005) 12 : 1123-1126. (Pubitemid 41324548)
56. AKINGBADE D, COHEN BJ, BROWN D.W.G.: Detection of low-avidity immunoglobulin G in oral fluid samples: new approach for Rubella diagnosis and surveillance. Clin. Diag. Lab. Immunol. (2003) 10 : 189-190. (Pubitemid 36133852)
57. PFREPPER K-I, ENDERS M, MOTZ M: Human Parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection. J. Vet. Med. (Series B) (2005) 52 : 362-365. (Pubitemid 44944264)
58. NARITA M, MATSUZONO Y, TAKEKOSHI Y et al. : Analysis of Mumps vaccine failure by means of avidity testing for Mumps virus-specific immunoglobulin G. Clin. Diagn. Lab. Immunol. (1998) 5 : 799-803. (Pubitemid 28519254)
59. BROWN SE, ZUCKERMAN AJ, HOWARD CR, STEWARD MW: Affinity of antibody response in man to hepatitis B vaccine determined with synthetic peptides. Lancet (1984) 2 : 184-187. (Pubitemid 14094954)
60. SULIGOI B, GALLI C, MASSI M et al. : Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J. Clin. Microbiol. (2002) 40 : 4015-4020. (Pubitemid 35285783)
61. http://www.biomedcentral.com/ 1471-2334/4/33 KNEITZ R-H, SCHUBERT J, TOLLMANN F et al. : A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid BMC Infectious Diseases.